Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012;2(2):183-7.
doi: 10.5681/apb.2012.028. Epub 2012 Aug 15.

Lactose engineering for better performance in dry powder inhalers

Yahya Rahimpour  1 , Hamed Hamishehkar
Affiliations
Review

Lactose engineering for better performance in dry powder inhalers

Yahya Rahimpour et al. Adv Pharm Bull. 2012.

Abstract

Dry powder inhaler (DPI) is generally formulated as a powder mixture of coarse carrier particles and micronized drug with aerodynamic diameters of 1-5 μm. Carrier particles are used to improve drug particle flowability, thus improving dosing accuracy, minimizing the dose variability compared with drug alone and making them easier to handle during manufacturing operations. Lactose is the most common and frequently used carrier in DPIs formulations and nowadays various inhalation grades of lactose with different physico-chemical properties are available on the market. Therefore, the purpose of this manuscript is to review evolution of lactose as a carrier in inhalable formulations, their production and the impact of its physico-chemical properties on drug dispersion. This review offers a perspective on the current reported studies to modify lactose for better performance in DPIs.

Keywords: Carrier; Dry powder inhaler; Lactose; Pulmonary drug delivery.

PubMed Disclaimer

References

    1. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm. 1994;101(1-2):1–13.
    1. Todo H, Okamoto H, Iida K, Danjo K. Effect of additives on insulin absorption from intratracheally administered dry powders in rats. Int J Pharm. 2001;220:101–10. - PubMed
    1. Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14:969–75. - PubMed
    1. Prime D, Atkins PJ, Slater A, Sumby B. Review of dry powder inhalers. Adv Drug Deliv Rev. 1997;26(1):51–8. - PubMed
    1. Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H. et al. Influence of carrier particle size, carrier ratio and addition of fine ternary particles on the dry powder inhalation performance of insulin-loaded plga microcapsules. Powder Technol. 2010;201:289–95.

LinkOut - more resources